Recurrent mutations such as NOTCH1, MYC, SF3B1, BRAF, TP53, XPO1, MED12, NFKBIE, and EGR2 are commonly seen in various subsets of CLL patients (14, 29, 92–95). Here, NFKBIE is linked to B-cell chronic lymphocytic leukemia.